Drug discovery: lessons from evolution
Author:
Open Access
- 10 November 2010
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 71 (4) , 497-503
Abstract
A common view within the pharmaceutical industry is that there is a problem with drug discovery and we should do something about it. There is much sympathy for this from academics, regulators and politicians. In this article I propose that lessons learnt from evolution help identify those factors that favour successful drug discovery. This personal view is influenced by a decade spent reviewing drug development programmes submitted for European regulatory approval. During the prolonged gestation of a new medicine few candidate molecules survive. This process of elimination of many variants and the survival of so few has much in common with evolution, an analogy that encourages discussion of the forces that favour, and those that hinder, successful drug discovery. Imagining a world without vaccines, anaesthetics, contraception and anti-infectives reveals how medicines revolutionized humanity. How to manipulate conditions that favour such discoveries is worth consideration.Keywords
This publication has 29 references indexed in Scilit:
- Hope in translationNature, 2010
- China pushes for the proteomeNature, 2010
- Patent fixes for EuropeNature, 2010
- Early warning signals of extinction in deteriorating environmentsNature, 2010
- Sir James Black (1924–2010)British Journal of Pharmacology, 2010
- Clinical pharmacology and therapeutics in the UK – a great instaurationBritish Journal of Clinical Pharmacology, 2010
- The impact of clinical trials legislation on clinical pharmacology: problems and solutionsBritish Journal of Clinical Pharmacology, 2009
- Preventing cancerNature, 2006
- Rational Approaches to the Design of Therapeutics Targeting Molecular Markers: The Case of Chronic Myelogenous LeukemiaAnnals of the New York Academy of Sciences, 2004
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999